Equities research analysts forecast that Merit Medical Systems, Inc. (NASDAQ:MMSI) will report earnings of $0.32 per share for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Merit Medical Systems’ earnings, with the highest EPS estimate coming in at $0.33 and the lowest estimate coming in at $0.30. Merit Medical Systems posted earnings of $0.31 per share during the same quarter last year, which suggests a positive year over year growth rate of 3.2%. The company is expected to report its next quarterly earnings results on Tuesday, February 20th.
According to Zacks, analysts expect that Merit Medical Systems will report full-year earnings of $1.27 per share for the current fiscal year, with EPS estimates ranging from $1.25 to $1.28. For the next financial year, analysts expect that the business will report earnings of $1.42 per share, with EPS estimates ranging from $1.42 to $1.44. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Merit Medical Systems.
Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.02. The business had revenue of $179.30 million during the quarter, compared to the consensus estimate of $181.28 million. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The firm’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.26 earnings per share.
Several analysts have issued reports on the stock. Raymond James Financial, Inc. reissued an “outperform” rating and issued a $44.00 price objective on shares of Merit Medical Systems in a research note on Monday, August 28th. Citigroup Inc. downgraded shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating and set a $44.00 price objective for the company. in a research note on Monday, August 28th. They noted that the move was a valuation call. UBS AG downgraded shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a research note on Monday, August 28th. Zacks Investment Research raised shares of Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 price objective for the company in a research note on Saturday, October 28th. Finally, Canaccord Genuity reaffirmed a “buy” rating and set a $45.00 price target on shares of Merit Medical Systems in a research note on Wednesday, September 6th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. Merit Medical Systems has a consensus rating of “Buy” and a consensus price target of $42.02.
COPYRIGHT VIOLATION WARNING: This piece of content was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/12/05/analysts-expect-merit-medical-systems-inc-mmsi-to-announce-0-32-earnings-per-share.html.
Shares of Merit Medical Systems (NASDAQ MMSI) opened at $40.60 on Monday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.78 and a quick ratio of 1.43. The stock has a market cap of $2,038.07, a PE ratio of 31.97, a price-to-earnings-growth ratio of 2.75 and a beta of 1.20. Merit Medical Systems has a 12 month low of $23.00 and a 12 month high of $45.50.
In other news, Director Kent W. Stanger sold 670 shares of Merit Medical Systems stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $42.06, for a total transaction of $28,180.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 5.00% of the company’s stock.
A number of large investors have recently modified their holdings of the stock. Wolverine Trading LLC bought a new position in Merit Medical Systems in the third quarter worth approximately $226,000. Insight Capital Research & Management Inc. bought a new position in Merit Medical Systems in the third quarter worth approximately $1,258,000. Neuberger Berman Group LLC raised its stake in Merit Medical Systems by 1,420.2% in the third quarter. Neuberger Berman Group LLC now owns 304,049 shares of the medical instruments supplier’s stock worth $12,876,000 after buying an additional 284,049 shares in the last quarter. California Public Employees Retirement System raised its stake in Merit Medical Systems by 5.9% in the third quarter. California Public Employees Retirement System now owns 142,092 shares of the medical instruments supplier’s stock worth $6,018,000 after buying an additional 7,892 shares in the last quarter. Finally, Point72 Asset Management L.P. bought a new position in Merit Medical Systems in the third quarter worth approximately $8,889,000. 89.47% of the stock is owned by institutional investors.
Merit Medical Systems Company Profile
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.